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660a Wednesday, February 29, 2012very different structural flexibility and fluctuations in their inward-facing
states, especially with regard to the separation of the NBDs. Comparing the dy-
namics of NBDs, it becomes evident that ABC importers fluctuate significantly
lower than ABC exporters, suggesting that the conformational ensembel ob-
tained for the former represents a deeper energy well. In contrast, the NBDs
of P-glycoprotein are able to reach near dimerized conformations even in the
absence of the nucleotide due to the overall higher structural flexibility of
the protein architecture. The dynamical difference between the two ABC trans-
porters appears to present a fundamental mechanistic difference between the
subfamilies they belong to, which can be described as different energy land-
scapes along their pathways for NBD dimerization. The difference in energy
landscapes is evidenced by their transport activities in that the NBDs of the
maltose transporter dimerize only in the presence of its substrate, whereas P-
glycoprotein possesses a remarkable substrate-independent ATPase activity.
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LmrP, a Major Facilitator Superfamily (MFS) multidrug transporter from Lac-
tococcus lactis, acts a secondary antiporter, catalysing the extrusion of a large
spectrum of hydrophobic drugs by dissipating a proton gradient. This implies
that it has evolved to bind and export a series of structurally diverse cytotoxic
substances from within the membrane, in contrast to the majority of MFS trans-
porters that are specialized in the transport of a single soluble substrate, cap-
tured from the aqueous medium. Its transport mechanism could thus
potentially differ from the alternating access model of the lactose permease
that currently stands as a paradigm for all MFS transporters. Using Electron
Paramagnetic Resonance spectroscopy on a library of cysteine mutants, labeled
with either one or two spin probes, we aim at mapping the conformational dy-
namics of LmrP during its transport cycle. We are using accessibility patterns
and intramolecular distance changes to understand the conformational rear-
rangements involved in the energization and subsequent substrate recognition
and extrusion mechanisms of the transporter. Preliminary measurements on
a first set of mutants show profound structural changes upon ligand binding
or protonation of key acidic residues. In particular, we observe a significant
conformational rearrangement of helix VIII upon substrate binding, suggesting
that the interface between the N- and C-terminal halves could be key in the con-
trolled access of drugs to the substrate binding pocket. These findings could
shed light on the mechanistical divergence with MFS transporters recognizing
soluble substrates from the extracellular medium. Based on these first results,
we present a blueprint of the catalytic cycle of LmrP.
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Major Facilitator Superfamily (MFS) transporters harness the free energy stored
in ion or solute gradients for active transport of a variety of substrates. Although
most of the 58 distinct families of MFS transporters are substrate-specific, six
families contain multidrug transporters (MDR). EmrD is a MFS-MDR from
E.coli whose crystal structure has been determined. Similar to the lac permease,
the topology consists of 12 transmembrane helices arranged in two bundles of
six helices. However, EmrD has a more compact conformation that occludes ac-
cess to a hydrophobic cavity/chamber from both sides of the membranes. To de-
fine the conformational motion involved in substrate transport, we are using spin
labeling and electron paramagnetic resonance (EPR) spectroscopy. Spin labels
were introduced at selected sites along transmembrane helices 5, 6 and 8. EPR
analysis of mobilities and accessibilities reveal distinct changes in spin label dy-
namics and exposure to NiEDDA upon protonotation of the transporter. The
sites of these changes cluster at the periplasmic side of EmrD suggesting that
this end of the transporter undergoes conformational rearrangements at low
pH. Double electron electron resonance analysis is in progress to determine
the nature and amplitude of the protein conformational motion.
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Toronto, Toronto, ON, Canada.Bacteria evade the effects of cytotoxic compounds through the efflux activity of
membrane-bound transporters such as the small multidrug resistance (SMR)
proteins. Consisting typically of ca. 110 residues with four transmembrane
(TM) a-helices, crystallographic studies have shown that TM helices 1 through
3 of each monomer create a substrate binding ‘pocket’ within the membrane
bilayer, while a TM4-TM4 interaction accounts for the primary dimer forma-
tion. Previous work from our lab has characterized a highly conserved small
residue heptad motif in the Halobacterium salinarum transporter Hsmr as
90GLxLIxxGV98 that lies along the TM4-TM4 dimer interface of SMR pro-
teins as required for function. Here, we present our focus on the conserved po-
sitions 91, 93, 94, and 98 where we substituted the naturally occurring Hsmr
residue for Ala, Phe, Ile, Leu, Met, and Val at each position in the Hsmr
TM4-TM4 interface. Large residue replacements were studied for their ability
to dimerize on SDS-PAGE, to bind the cytotoxic compound ethidium bromide,
and to confer resistance by efflux. Although the relative activity of mutants did
not correlate to dimer strength for all mutants, all functional mutants lay within
þ/ 10% of dimerization relative to WT, suggesting that optimal dimer
strength at TM4 is required for proper efflux. Furthermore, non-functional sub-
stitutions at the centre of the dimerization interface that do not alter dimer
strength suggest a dynamic TM4-TM4 ‘pivot point’ that responds to the efflux
requirements of varying substrates. This functionally critical region represents
a potential target for inhibiting the ability of bacteria to evade the effects of
cytotoxic compounds.
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In E. coli, it is known that the tripartite multidrug efflux system (AcrB/AcrA/
TolC) exists, and AcrB resides in the inner membrane region and take part in
substrate recognition and energy transduction for drug export through proton
transfer.
Recently, x-ray structures provided that AcrB forms trimeric protein where
each protomer is different conformation, ‘‘binding’’, ‘‘extrusion’’ and ‘‘access’’
state.
Especially, the shapes of the tunnels of drug pathways in porter domains are
different. In addition, extrusion state protomer has the unique side chain con-
formations of residues which are essential for proton translocation, ‘‘proton
translation site’’ (Asp407, Asp408 and Lys940). These results suggest that
drugs are exported by a three-step structural change involved in the proton mo-
tive force which related with the conformational change in protonation sites. In
the present study, to clarify a relation between the small conformational change
of proton translation site and the large structural change of porter domain, we
performed all-atom molecular dynamics (MD) simulations of AcrB-
membrane-water system.
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The monoamine transporters (MATs) are a family of neurotransmitter trans-
porters located on the presynapse of a neuron. These monoamine transporters
regulate the levels of neurotransmitters available in the synapse to bind to
post-synaptic receptors. One of the MATs, the dopamine transporter (DAT)
is a target of various therapeutic and illicit drugs. The mechanism and confor-
mational states of the DAT is still widely debated. A driving force behind the
transport mechanism for DAT is the sodium gradient. We present an all-atom
MD study of the DAT at physiological concentrations of Naþ, Kþ and Cl-. A
dual POPE lipid bilayer system was constructed to impose an explicit sodium
gradient via two water baths. Six permeations of DAT states were simulated
that vary bound sodium ions and dopamine molecules. Trajectory data have
been analyzed to gain insight to the role of sodium and substrates in conforma-
tional changes of the DAT.
3355-Pos Board B216
Computer Simulations of the Multi-Drug Efflux Pump AcrAB-TolC
Nadine Fischer, Martin Raunest, Thomas H. Schmidt, Christian Kandt.
University of Bonn, Bonn, Germany.
Preventing drug access to the target molecule(s) is one of the major strategies
by which bacteria achieve antibiotics resistance. A prominent example of this
mode of action is drug expulsion by an over-production of multi-drug efflux
pumps like the proton drug antiporter AcrAB-TolC in Escherichia coli. Per-
forming atomistic molecular dynamics simulations of the pump and its compo-
nents in a membrane / water environment on a 50 ns - 1 ms time scale, we were
